GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mera Pharmaceuticals MRPI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2020

Net income

−$6

FY2020FY2020

Free cash flow

—

FY2020FY2020

Shareholders' equity

−$30

FY2020FY2020

Income statement

Fiscal years

FY2020
Operating income−$6
Net income−$6
Diluted earnings per share-0.00

Balance sheet

At each fiscal year end

FY2020
Total liabilities$30
Shareholders' equity−$30
Shares outstanding557m

Cash flow

Fiscal years

Latest quarters

By quarter end

Jul 2021Oct 2011Jul 2011Apr 2011Jan 2011Oct 2010Jul 2010Apr 2010
Revenue—$63,917$86,819$87,268$64,620$64,145$67,115$61,413
Gross profit—$61,684$86,535$77,061$61,084$28,480$67,115$52,318
Operating income−$1,365−$103,550−$20,064−$37,936−$39,504−$394,582−$52,580−$81,471
Net income−$1,365−$102,185−$15,750−$35,050−$34,695−$394,553−$48,118−$77,778
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets—$70,682$84,782$46,447$44,434$73,357$400,648$405,922
Cash and short-term investments—$4,315$4,008$1,267$6,979$5,940$850$3,200
Debt—$299,136$51,936$51,936$51,936—$51,936$51,936
Shareholders' equity−$38,649−$864,620−$762,435−$746,685−$711,635−$676,940−$282,387−$234,269

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-97.8%-92.2%-72.2%
Net income-97.8%-92.2%-71.9%

Valuation history

At each fiscal year end

FY2020
Price to earnings-936.3

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%500%256%-75%673984%17%42%1618%2244%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.